Severe hyperphosphatemia in a patient with chronic kidney disease and multiple myeloma–to strengthen the case toward renal replacement therapy?
Article first published online: 13 NOV 2013
© 2013 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Clinical Case Reports
Volume 1, Issue 2, pages 72–74, December 2013
How to Cite
Clinical Case Reports 2013; 1(2): 72–74
- Issue published online: 12 DEC 2013
- Article first published online: 13 NOV 2013
- Manuscript Accepted: 18 OCT 2013
- Manuscript Received: 9 AUG 2013
- Chronic kidney disease;
- multiple myeloma;
Key Clinical Message
We report a patient with multiple myeloma and chronic kidney disease who presented with severe hyperphosphatemia in the outpatient clinic without any related symptoms. Initial differential diagnosis: Tumor lysis syndrome or chronic kidney disease. Further work-up revealed pseudohyperphosphatemia. In general, treatment is not necessary if the true phosphate level is within the reference range and the patient is asymptomatic.